
GeoVax Accelerates GEO-MVA Vaccine Development Amid Global Mpox Crisis
GeoVax Labs, Inc. is expediting the development of its GEO-MVA Mpox vaccine in response to a global surge in cases, WHO's reaffirmed emergency status, and EMA's supportive guidance, highlighting the urgent need for scalable and equitable vaccine solutions.
Read full story


























